Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA

NCT05992142 is registered in ClinicalTrials.gov with Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW as lead sponsor.

NCT NCT05992142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05992142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA
Lead sponsor
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
Phase
Phase 4
Overall status
Completed
Start date
January 17, 2023
Completion date
February 1, 2024
Enrollment
200 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis